Phytomedicines targeting cancer stem cells: Therapeutic opportunities and prospects for pharmaceutical development
Loading...
Access rights
openAccess
publishedVersion
URL
Journal Title
Journal ISSN
Volume Title
A2 Katsausartikkeli tieteellisessä aikakauslehdessä
This publication is imported from Aalto University research portal.
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Date
Major/Subject
Mcode
Degree programme
Language
en
Pages
25
Series
Pharmaceuticals, Volume 14, issue 7
Abstract
The presence of small subpopulations of cells within tumor cells are known as cancer stem cells (CSCs). These cells have been the reason for metastasis, resistance with chemotherapy or radiotherapy, and tumor relapse in several types of cancers. CSCs underwent to epithelial– mesenchymal transition (EMT) and resulted in the development of aggressive tumors. CSCs have potential to modulate numerous signaling pathways including Wnt, Hh, and Notch, therefore increasing the stem-like characteristics of cancer cells. The raised expression of drug efflux pump and suppression of apoptosis has shown increased resistance with anti-cancer drugs. Among many agents which were shown to modulate these, the plant-derived bioactive agents appear to modulate these key regulators and were shown to remove CSCs. This review aims to comprehensively scrutinize the preclinical and clinical studies demonstrating the effects of phytocompounds on CSCs isolated from various tumors. Based on the available convincing literature from preclinical studies, with some clinical data, it is apparent that selective targeting of CSCs with plants, plant preparations, and plant-derived bioactive compounds, termed phytochemicals, may be a promising strategy for the treatment of relapsed cancers.Description
Funding Information: This research did not receive any specific grant from the funding agencies in the public, commercial, or not-for-profit sectors. The APC was paid by K.K.K. and J.R. (Department of Applied Physics, Aalto University, Finland). Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Other note
Citation
Gupta, P K, Saraff, M, Gahtori, R, Negi, N, Tripathi, S K, Kumar, J, Kumar, S, Aldhayan, S H, Dhanasekaran, S, Abomughaid, M M, Dua, K, Gundamaraju, R, Ojha, S, Ruokolainen, J, Jha, N K & Kesari, K K 2021, 'Phytomedicines targeting cancer stem cells : Therapeutic opportunities and prospects for pharmaceutical development', Pharmaceuticals, vol. 14, no. 7, 676. https://doi.org/10.3390/ph14070676